Here are the top stories from the last week:

Exclusive Q&A: Walgreens unveils Community Practice Shared Faculty Program
Walgreens is expanding its partnership with pharmacy schools by launching the Walgreens Community Practice Shared Faculty Program.
Read article »

Charitable clinics, pharmacies to receive share in $1.6M in Equity Rx grants from Cardinal Health Foundation
The Cardinal Health Foundation is distributing $1.6 million in grants to charitable clinics and pharmacies, addressing rising patient demand.
Read article »

NACDS commends states for commitment to advancing rural health
The National Association of Chain Drug Stores is advocating for pharmacy advancements in rural health.
Read article »

Essity acquires Edgewell's feminine care business in North America for $340M
Essity has acquired Edgewell's feminine care business in North America, including brands like Carefree, Stayfree, and o.b.
Read article »

Hy-Vee Expands Footprint with Specialty Pharmacy Acquisition
Hy-Vee, a Midwestern grocery store chain, has acquired Amber Pharmacy to expand its presence in the specialty drug market. This acquisition is part of Hy-Vee's strategy to meet the growing demand for specialty medications, which are expected to surpass traditional drugs in volume by 2018. The move will allow Hy-Vee to offer a wider range of medications across its locations, enhancing its health and wellness services.
Read article »

RedSail Technologies acquires RxMile
RedSail Technologies acquired RxMile, a delivery management platform for pharmacies, enhancing delivery operations with real-time tracking and compliance. This acquisition aims to empower pharmacies with efficient delivery solutions.
Read article »

National COO Spina excited about opportunities at Walgreens
Anthony Spina, the new COO of Walgreens, expressed enthusiasm for future opportunities at the company, highlighting his experience and commitment to improving retail pharmacy services.
Read article »

Proposed acetaminophen warning conflicts with FDA's standard
The CHPA urged the FDA to reject a petition for new warnings on acetaminophen products, arguing that current evidence does not support claims linking acetaminophen to autism and ADHD.
Read article »

Padagis gets New York State Department of Health Naloxone contract
Padagis was selected by New York State to supply naloxone, aiming to expand access to opioid overdose treatment while reducing costs through generic options.
Read article »

‍

‍

‍